{"title":"Technological Forecasting on Phytotherapics Development in Brazil","authors":"Sim\u00f5es, Evelyne Rolim Braun, Marques, Lana Grasiela Alves, Soares, Bruno Marques Pinheiro, Daniel Pascoalino, Santos, Maria Rita Morais Chaves, Pessoa, Claudia","volume":67,"journal":"International Journal of Computer and Systems Engineering","pagesStart":286,"pagesEnd":291,"ISSN":"1307-6892","URL":"https:\/\/publications.waset.org\/pdf\/10074","abstract":"
The prospective analysis is presented as an important tool to identify the most relevant opportunities and needs in research and development from planned interventions in innovation systems. This study chose Phyllanthus niruri, known as "stone break" to describe the knowledge about the specie, by using biotechnological forecasting through the software Vantage Point. It can be seen a considerable increase in studies on Phyllanthus niruri in recent years and that there are patents about this plant since twenty-five years ago. India was the country that most carried out research on the specie, showing interest, mainly in studies of hepatoprotection, antioxidant and anti-cancer activities. Brazil is in the second place, with special interest for anti-tumor studies. Given the identification of the Brazilian groups that exploit the species it is possible to mediate partnerships and cooperation aiming to help on the implementing of the Program of Herbal medicines (phytotherapics) in Brazil.<\/p>\r\n","references":"[1] M. G. Castro, et al, \"An\u251c\u00edlise prospectiva de cadeias produtivas\r\nagropecu\u251c\u00edrias\".Available:http:\/\/www.gestaoct.org.br\/forum_municipal\/a\r\npresent\/cd_anton_ maria\/anal_prospectiva _cp_ agropec. pdf .\r\n[2] Andr\u00e9ia M. Pereira, \"Condicionantes Institucionais para bioprospec\u251c\u00ba\u251c\u00fao\r\nno Brasil,\" (tese). Campinas: Instituto de Economia\/UNICAMP, 2009,\r\npp. 52, 65.\r\n[3] Daniel R. Santos, \"Ch\u251c\u00ed de quebra-pedra na lit\u251c\u00a1ase urin\u251c\u00edria em humanos\r\ne em ratos,\" (tese), S\u251c\u00fao Paulo: Escola Paulista de Medicina, 1990, pp.\r\n189.\r\n[4] Minist\u00e9rio da Sa\u251c\u2551de (BR). Programa Nacional de Plantas Medicinais e\r\nFitoter\u251c\u00edpicos,2007.Available:http:\/\/portal.saude.gov.br\/portal\/arquivos\/p\r\ndf\/politica_plantas_medicinais_fitoterapia.pdf.\r\n[5] R. F. Menezes, \"Hist\u251c\u2502ria da farm\u251c\u00edcia e dos medicamentos.\" Available:\r\nhttp:\/\/acd.ufrj.br\/consumo\/leituras\/lm_historiafarmaciamed.pdf.\r\n[6] Gilberto P. Souza and Luiz C. Cestas, \"Relat\u251c\u2502rio setorial farmac\u251c\u00acutico -\r\nIn\u251c\u00a1cio de cobertura. Olhando o Futuro\", jul 2006. Available:\r\nhttp:\/\/pt.scribd.com\/api_user_11797_jreg84\/d\/7018731-250706-\r\nRelatorio-Setorial-Farmaceutico-Inicio-de-Cobertura.\r\n[7] L. X. L. Capanema and P. L. Palmeira Filho, \"A ind\u251c\u2551stria farmac\u251c\u00acutica\r\nnacional: desafios rumo \u251c\u00e1 inser\u251c\u00ba\u251c\u00fao global. 2009,\" in Ana C. Al\u00e9m and F.\r\nGiambiagi, \"O BNDES em um Brasil em transi\u251c\u00ba\u251c\u00fao\". Rio de Janeiro:\r\nBNDES, 2010, pp. 165-166.\r\n[8] World Health Organization. Traditional medicine. Fact sheet n\u00ba. 134.\r\nGeneva: WHO, 2003.\r\n[9] P. M. P. Ferreira, et al, \"Moringa oleifera: bioactive compounds and\r\nnutritional potential. Revista de Nutri\u251c\u00ba\u251c\u00fao, vol. 21, pp. 431-437, 2008.\r\n[10] David J. Newman, Gordon M. Cragg and Kenneth M. Snader, \"Natural\r\nproducts as a source of new drugs over the period 1981-2002. Journal\r\nNatural Product, vol. 66, pp. 1022-1037, 2003.\r\n[11] A. J. Beattie, \"New products and industries from biodiversity,\" in R.\r\nHassan, R. Scholes and N. Ash. \"Ecosystems and human well-being,\":\r\ncurrent state and trends. Washington: Islandpress, 2005, vol. 1, pp. 272-\r\n296.\r\n[12] Institute for Healthcare Informatics, \"The Global use of medicines:\r\noutlook trough 2015\". 2011. Available:\r\nhttp:\/\/www.imshealth.com\/deployedfiles\/ims\/ Global\/Content\r\n\/Insights\/IMS%20Institute %\r\n20for%20Healthcare%20Informatics\/Global_Use_of_Medicines_Report\r\n.pdf.\r\n[13] Fitoterapia. Entre o conhecimento popular e o cient\u251c\u00a1fico. 2007.\r\nAvailable: http:\/\/www.comciencia.br\/reportagens\/fito\/fito1.htm.\r\n[14] Associa\u251c\u00ba\u251c\u00fao Brasileira das Empresas do Setor Fitoter\u251c\u00edpico-ABIFISA.\r\nSuplemento alimentar e de promo\u251c\u00ba\u251c\u00fao da sa\u251c\u2551de. Available:\r\nhttp:\/\/www.abifisa.org.br.\r\n[15] J.A.S. Zuanazzi and P. Mayorga, \"Fitoprodutos e desenvolvimento\r\necon\u251c\u2524mico\". Qu\u251c\u00a1mica Nova, vol. 33, n\u00ba. 6, pp. 1421-1429, 2010?\r\n[16] Minist\u00e9rio do Meio Ambiente (BR). Regras para o acesso legal ao\r\npatrim\u251c\u2524nio gen\u00e9tico e conhecimento tradicional associado. Bras\u251c\u00a1lia:\r\nDepartamento do Patrim\u251c\u2524nio Gen\u00e9tico, 2007.\r\n[17] Minist\u00e9rio da Sa\u251c\u2551de (BR). Pol\u251c\u00a1tica Nacional de Plantas Medicinais e\r\nFitoter\u251c\u00edpicos,2006.Available:http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\r\n\/politica_nacional_ fitoterapicos.pdf.\r\n[18] Brasil, \"RDC n\u252c\u2591 14, de 31 de Mar\u251c\u00bao de 2010,\" Estabelece os requisitos\r\nm\u251c\u00a1nimos para o registro de medicamentos fitoter\u251c\u00edpicos. Available:\r\nhttp:\/\/www.institutosalus.com\/_arquivos\/diversos\/rdc-14-2010. pdf .\r\n[19] Brasil, \"Medida Provis\u251c\u2502ria n\u00ba 2.186-16, de 23 de agosto de 2001\".\r\nAvailable: http:\/\/www.planalto.gov.br\/ccivil\/mpv\/2186-16.htm.\r\n[20] Brasil, \"Delibera\u251c\u00ba\u251c\u00fao n\u00ba 40, de 24 de Setembro de 2003\". Credencia o\r\nInstituto Brasileiro do Meio Ambiente e dos Recursos Naturais\r\nRenov\u251c\u00edveis - IBAMA, para autorizar outras institui\u251c\u00ba\u251c\u00c1es a realizar as\r\natividades que especifica. Available:http:\/\/www.museugoeldi.\r\nbr\/institucional\/del40.pdf.\r\n[21] Marcio M. Santos, et al, \"Prospec\u251c\u00ba\u251c\u00fao de tecnologias de futuro: m\u00e9todos,\r\nt\u00e9cnicas e abordagem,\" Parcerias Estrat\u00e9gicas, n.19, pp. 190, 207,208,\r\n2004.\r\n[22] A. M. S. Antunes and J. L. Magalh\u251c\u00faes, \"Patenteamento & prospec\u251c\u00ba\u251c\u00fao\r\ntecnol\u251c\u2502gica no setor farmac\u251c\u00acutico,\" Rio de Janeiro: Interci\u251c\u00acncia, 2008.\r\n[23] Associa\u251c\u00ba\u251c\u00fao Brasileira dos Analistas de Intelig\u251c\u00acncia Competitiva-\r\nABAIC, \"Intelig\u251c\u00acncia competitiva\". Available:\r\nhttp:\/\/www.abraic.org.br\/site\/faqs.asp.\r\n[24] M. Zackiewicz and S. Salles-Filho, \"Technological foresight: um\r\ninstrumento para pol\u251c\u00a1tica cient\u251c\u00a1fica e tecnol\u251c\u2502gica,\" Parcerias\r\nEstrat\u00e9gicas, n\u00ba. 10, pp. 144-161, 2001\r\n[25] Instituto Nacional de Tecnologia, Prospec\u251c\u00ba\u251c\u00fao Tecnol\u251c\u2502gica:\r\nMetodologias e Experi\u251c\u00acncias Nacionais e Internacionais, 2003.\r\nAvailable: http:\/\/www.davi.ws\/prospeccao_tecnologica.pdf.\r\n[26] J. Gruenwald, editor, \"PDR for herbal medicines,\" 2nd ed. New Jersey:\r\nMedical Economics, 2000, pp. 91-92.\r\n[27] Lily M. Perry and J. Metzger, \"Medicinal plants of the east southeast\r\nasia: attributed properties and uses\". Cambridge: MIT Press, 1980, pp.\r\n150.\r\n[28] M. P. Corr\u251c\u00aca, \"Dicion\u251c\u00edrio das plantas \u251c\u2551teis do Brasil e das ex\u251c\u2502ticas\r\ncultivadas,\" Rio de Janeiro: IBDF, 1984.\r\n[29] A. M. Freitas, M. Schor and M. A. Boim, \"The effect of Phyllanthus\r\nniruri on urinary inhibitors of calcium oxalate crystalisation and other\r\nfactors associated with renal stone formation. Br. J. Urol. International,\r\nvol. 89, n. 9, pp. 829-834, 2002.\r\n[30] S. P. Thyagarajan, et al. \"Herbal medicines for liver diseases in India,\"\r\nJournal of Gastroenterology and Hepatology, vol. 17, suppl. 3, pp. 370-\r\n376, 2002.\r\n[31] Farouk, A. K. Bashir and A. K. M. Salih, \"Antimicrobial activity of\r\ncertain sudanese plants used in folkloric medicine. Screening for\r\nantibacterial activity (I). Fitoterapia, vol. 54, n.1, pp. 3-7, 1983.\r\n[32] S. M. Sabir and J. B. T. Rocha Water-extractable phytochemicals from\r\nPhyllanthus niruri exhibit distinct in vitro antioxidant and in vivo\r\nhepatoprotective activity against paracetamol-induced liver damage in\r\nmice. Food Chemistry, vol. 4, pp. 845, 2008.\r\n[33] Adair R.S. Santos, et al, \"Further studies on the antinociceptive action of\r\nthe hydroalcoholic extract from plants of the genus Phyllanthus\",\r\nJournal of Pharmacy Pharmacology, vol. 47, n. 1, pp. 66-71, 1995.\r\n[34] P. Sharma et al, \"Anti-tumor activity of Phyllanthus niruri (a medicinal\r\nplant) on chemical-induced skin carcinogenesis in mice,\" Asian Pacific\r\nJournal of Cancer Prevention, vol. 13, pp. 1089-1094, 2009.","publisher":"World Academy of Science, Engineering and Technology","index":"Open Science Index 67, 2012"}